Research article · 31 Mar 2015
Research articlePublished 2014
New Antihypertensive Tablets Formulation and HPLC Analyses Using New Generation Core Shell Column
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives: Formulation of triplet combined solid dosage film coated tablet containing amlodipine besylate (equivalent to 5 mg amlodipine), hydrochlorothiazide (12.5 mg) and losartan potassium (50 mg) for the treatment of severe hypertension. Development and validated of a simple, fast, precise, selective and accurate HPLC method for the simultaneous determination of amlodipine besylate, hydrochlorothiazide and losartan potassium in the tablets. Methods: The formulation of the tablets was carried out as per standard protocols. The various steps involve in formulation were dispensing of raw materials, sieving, preparation of granulating solvent, mixing, granulation, drying (In FBD), lubrication, compression and coating. The separation of these three drugs was achieved on a Sun Shell C8 column (150 mm x 4.6 mm, 2.6 μm) with phosphate buffer-acetonitrile (70:30% v/v) as mobile phase at 1.0 mL/min flow rate and 230 nm detection. Results and Conclusion: The physical parameters of tablets were satisfactory with average weight deviation from 3.23 to 3.29%, friability 0.04%, disintegration time 8.3 minutes, average hardness 85.43N and thickness from 3.92 to 4.01 mm. The assay was found to be 99.89%, 99.99% and 99.97% of amlodipine, hydrochlorothiazide and losartan potassium, respectively. The dissolution was found to be 98.8 to 99.70%, 97.85 to 98.95% and 97.98 to 99.99% of amlodipine, hydrochlorothiazide and losartan potassium, respectively. The uniformity of content was 99.85 to 99.99% and 99.60 to 99.99% of amlodipine and hydrochlorothiazide, respectively. The retention times observed were to be 7.338, 2.097 and 10.675 minutes for amlodipine besylate, hydrochlorothiazide and losartan potassium, respectively. The method was statistically validated for linearity, recovery, limit of detection, limit of quantification, accuracy,precision, robustness, stability of drugs in pure form and in presence of matrices and forced degradation study. The method was successfully applied for analysis of combined dose tablet.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2015
Novel SPE-HPLC Method for Analyses of β-Blockers in Human Plasma Using New Generation Phenyl-Ethyl Column
Article · 2015
Novel SPE-HPLC Method for Analyses of Ã?ŽÃ?²-Blockers in Human Plasma Using New Generation Phenyl-Ethyl Column
Research article · 3 May 2019
Development and Validation of HPLC Method for Simultaneous Determination of Three Constituent in 4-FDC Tablet by Pre-Column Derivatization
Research article · 2016
Development and Validation of Spectrophotometric and Pre-column Derivatization HPLC Method for Determination of Famotidine in Pharmaceuticals by Reaction with Sodium Nitroprusside; Application to Combined Tablets
More from this journal
The newest in American Journal of Advanced Drug Delivery.
Article · 18 Jan 2025
Nose to Brain Drug Delivery System
Article · 30 Dec 2024
Protein and Peptide Drug Delivery: Challenges and Innovations
Article · 30 Dec 2024
Process Design and Optimization of Drug Delivery Systems
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAmerican Journal of Advanced Drug Delivery
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kamlesh K. Dutta”
- BylineArticles whose byline prints “Zeid A. Al-Othman”
- BylineArticles whose byline prints “Govinda Manda”
- BylineArticles whose byline prints “Imran Ali”
